Neil G Berry Selected Research

Ligands

4/2012

Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methods.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil G Berry Research Topics

Disease

8	Malaria 01/2024 - 03/2012
4	Hypersensitivity (Allergy) 11/2015 - 06/2005
2	Snake Bites (Snake Bite) 01/2023 - 01/2023
2	Infections 01/2019 - 02/2006
1	Tuberculosis (Tuberculoses) 10/2023
1	Persistent Infection 10/2023
1	Acute Coronary Syndrome 01/2023
1	Alkaptonuria 07/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2019
1	Neoplasms (Cancer) 10/2019
1	Inflammation (Inflammations) 10/2019
1	Neglected Diseases 01/2019
1	TDP-43 Proteinopathies 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018
1	Human Influenza (Influenza) 01/2018
1	Fibrosarcoma 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 03/2016
1	Lung Neoplasms (Lung Cancer) 05/2013
1	Poisoning 09/2011
1	Hepatitis B 06/2011

Drug/Important Bio-Agent (IBA)

5	Antimalarials (Antimalarial Agents)IBA 01/2024 - 03/2012
4	EnzymesIBA 07/2022 - 03/2012
3	Phosphates (Orthophosphate)IBA 11/2016 - 03/2012
2	Oxidoreductases (Dehydrogenase)IBA 10/2023 - 03/2012
2	abacavir (Ziagen)FDA Link 11/2015 - 04/2014
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 03/2012 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 09/2011 - 09/2011
1	CytochromesIBA 10/2023
1	Antitubercular AgentsIBA 10/2023
1	duroquinol oxidaseIBA 10/2023
1	Snake Venoms (Snake Venom)IBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	VenomsIBA 01/2023
1	varespladibIBA 01/2023
1	Phospholipases A2 (Phospholipase A2)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 07/2022
1	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 07/2022
1	AnthelminticsIBA 01/2019
1	methsuximide (mesuximide)FDA Link 10/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	2-oxindole (oxindole)IBA 01/2018
1	nitazoxanide (NTZ)FDA Link 01/2018
1	raf KinasesIBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 03/2016
1	bardoxoloneIBA 03/2016
1	Epoxy Compounds (Epoxides)IBA 03/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2015
1	MMV008138IBA 04/2015
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2015
1	NucleosidesIBA 04/2014
1	Reverse Transcriptase InhibitorsIBA 04/2014
1	HLA-B57 antigenIBA 04/2014
1	ArtemisininsIBA 05/2013
1	QuinolonesIBA 05/2012
1	LigandsIBA 04/2012
1	ProdrugsIBA 03/2012
1	SaltsIBA 03/2012
1	7- chloro- 3- methyl- 2- (4- (4- (trifluoromethoxy)benzyl)phenyl)quinolin- 4(1H)- oneIBA 03/2012
1	Heme (Haem)IBA 09/2011
1	Carbon MonoxideIBA 09/2011
1	HaptensIBA 09/2011
1	Penicillins (Penicillin)FDA Link 09/2011
1	2- hydroxybenzoyl- N- (5- chlorothiazol- 2- yl)amideIBA 06/2011
1	3- (3- bromophenyl)- 5,7- dihydroxy- 4- oxo- 4H- chromene- 2- carboxylic acid ethyl esterIBA 02/2006
1	IsoflavonesIBA 02/2006
1	indeneIBA 06/2005
1	AnticoagulantsIBA 06/2005
1	Phenindione FDA Link 06/2005

Therapy/Procedure

4	Therapeutics 01/2024 - 11/2016
1	Oral Administration 03/2012